Please enable JavaScript to continue using this application.

Compare $ANIK vs $IPSC | Chartloom

Compare

$ANIK vs $IPSC

Anika Therapeutics Inc · Century Therapeutics Inc

ANIK

Anika Therapeutics Inc

IPSC

Century Therapeutics Inc

Compare $ANIK vs $IPSC

Comparing Anika Therapeutics Inc and Century Therapeutics Inc

ANIKAnika Therapeutics Inc

IPSCCentury Therapeutics Inc

ANIKAnika Therapeutics Inc

Market cap

$262M

P/E (TTM)

—

Forward P/E (NTM)

57.30x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

-2.5%

YTD performance

109.4%

52W performance

111.9%

FCF yield

0.2%

IPSCCentury Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

47.8%

52W performance

151.9%

FCF yield

-33.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIK

IPSC

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

IPSC

Century Therapeutics Inc

Market Cap

ANIK$262M

IPSC$265M

Enterprise Value

ANIK$224M

IPSC$215M

Price

ANIK$19.58

IPSC$1.47

P/E Ratio

ANIKN/A

IPSCN/A

P/S Ratio

ANIK2.17x

IPSC2.41x

EV/Sales

ANIK1.85x

IPSC1.98x

EV/EBITDA

ANIK84.97x

IPSC0.00x

P/B Ratio

ANIK1.86x

IPSC1.19x

P/FCF Ratio

ANIK466.16x

IPSCN/A

EV/FCF

ANIK397.81x

IPSC-2.44x

PEG Ratio

ANIKN/A

IPSCN/A

Forward P/E (NTM)

ANIK57.30x

IPSCN/A

Forward P/S (NTM)

ANIK2.09x

IPSCN/A

Revenue (TTM)

ANIK$121M

IPSC$0

Revenue Growth (YoY)

ANIK-2.5%

IPSC-100.0%

Forward Rev Growth

ANIK5.2%

IPSC385.7%

Gross Margin (TTM)

ANIK62.2%

IPSC0.0%

Operating Margin (TTM)

ANIK0.0%

IPSC0.0%

EBITDA Margin (TTM)

ANIK2.2%

IPSC0.0%

Net Margin (TTM)

ANIK-3.1%

IPSC0.0%

FCF Margin (TTM)

ANIK0.5%

IPSCN/A

Net Income (TTM)

ANIK$-4M

IPSC$-110M

FCF (TTM)

ANIK$562K

IPSC$-88M

EPS (TTM)

ANIK-$0.28

IPSC-$0.53

ROE (TTM)

ANIK-270.0%

IPSC-5276.0%

ROA (TTM)

ANIK-204.0%

IPSC-4059.0%

ROIC (TTM)

ANIK-270.0%

IPSC-5276.0%

Cash

ANIK$38M

IPSC$50M

Debt

ANIK$0

IPSC$0

Net Cash/Debt

ANIK$38M

IPSC$50M

Current Ratio (TTM)

ANIK4.48x

IPSC8.28x

Quick Ratio (TTM)

ANIK3.05x

IPSC7.94x

Debt/Equity (TTM)

ANIK0.00x

IPSC0.00x

Debt/Assets (TTM)

ANIK0.0%

IPSC0.0%

Interest Coverage (TTM)

ANIKN/A

IPSCN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

IPSC0.00x

Beta

ANIK0.23

IPSC1.74

52W Performance

ANIK111.9%

IPSC151.9%

YTD Performance

ANIK109.4%

IPSC47.8%

% from 52W High

ANIK-14.4%

IPSC-51.6%

% from 52W Low

ANIK125.8%

IPSC237.9%

Asset Turnover (TTM)

ANIK0.65x

IPSC0.31x

FCF Yield (TTM)

ANIK0.2%

IPSC-33.3%

Earnings Yield (TTM)

ANIK-1.4%

IPSC-41.4%

Dividend Yield (TTM)

ANIKN/A

IPSCN/A

Rule of 40

ANIK-2.0

IPSC-100.0

EV/GP/RG

ANIK0.81

IPSCN/A

Ticker research

View ANIK research View IPSC research

Metric	ANIK Anika Therapeutics Inc	IPSC Century Therapeutics Inc
Market & Valuation
Market Cap	$262M	$265M
Enterprise Value	$224M	$215M
Price	$19.58	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	2.41x
EV/Sales	1.85x	1.98x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	1.19x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-2.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	N/A
Revenue & Growth
Revenue (TTM)	$121M	$0
Revenue Growth (YoY)	-2.5%	-100.0%
Forward Rev Growth	5.2%	385.7%
Profitability
Gross Margin (TTM)	62.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	0.0%
Net Margin (TTM)	-3.1%	0.0%
FCF Margin (TTM)	0.5%	N/A
Net Income (TTM)	$-4M	$-110M
FCF (TTM)	$562K	$-88M
EPS (TTM)	-$0.28	-$0.53
ROE (TTM)	-270.0%	-5276.0%
ROA (TTM)	-204.0%	-4059.0%
ROIC (TTM)	-270.0%	-5276.0%
Financial Health
Cash	$38M	$50M
Debt	$0	$0
Net Cash/Debt	$38M	$50M
Current Ratio (TTM)	4.48x	8.28x
Quick Ratio (TTM)	3.05x	7.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.74
52W Performance	111.9%	151.9%
YTD Performance	109.4%	47.8%
% from 52W High	-14.4%	-51.6%
% from 52W Low	125.8%	237.9%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.31x
FCF Yield (TTM)	0.2%	-33.3%
Earnings Yield (TTM)	-1.4%	-41.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	-100.0
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View IPSC research

Valuation

P/S Ratio

ANIK

2.17x

IPSC

2.41x

EV/FCF

IPSC

-2.44x

ANIK

397.81x

Growth & revenue

Revenue Growth TTM

ANIK

-2.5%

IPSC

-100.0%

Forward Revenue Growth

IPSC

385.7%

ANIK

5.2%

Profitability & performance

Gross Margin

ANIK

62.2%

IPSC

0.0%

ROE

ANIK

-270.0%

IPSC

-5276.0%

FCF Yield %

ANIK

0.2%

IPSC

-33.3%

52-Week Performance

IPSC

151.9%

ANIK

111.9%

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

IPSC

Century Therapeutics Inc

Market Cap

ANIK$262M

IPSC$265M

Enterprise Value

ANIK$224M

IPSC$215M

Price

ANIK$19.58

IPSC$1.47

P/E Ratio

ANIKN/A

IPSCN/A

P/S Ratio

ANIK2.17x

IPSC2.41x

EV/Sales

ANIK1.85x

IPSC1.98x

EV/EBITDA

ANIK84.97x

IPSC0.00x

P/B Ratio

ANIK1.86x

IPSC1.19x

P/FCF Ratio

ANIK466.16x

IPSCN/A

EV/FCF

ANIK397.81x

IPSC-2.44x

PEG Ratio

ANIKN/A

IPSCN/A

Forward P/E (NTM)

ANIK57.30x

IPSCN/A

Forward P/S (NTM)

ANIK2.09x

IPSCN/A

Revenue (TTM)

ANIK$121M

IPSC$0

Revenue Growth (YoY)

ANIK-2.5%

IPSC-100.0%

Forward Rev Growth

ANIK5.2%

IPSC385.7%

Gross Margin (TTM)

ANIK62.2%

IPSC0.0%

Operating Margin (TTM)

ANIK0.0%

IPSC0.0%

EBITDA Margin (TTM)

ANIK2.2%

IPSC0.0%

Net Margin (TTM)

ANIK-3.1%

IPSC0.0%

FCF Margin (TTM)

ANIK0.5%

IPSCN/A

Net Income (TTM)

ANIK$-4M

IPSC$-110M

FCF (TTM)

ANIK$562K

IPSC$-88M

EPS (TTM)

ANIK-$0.28

IPSC-$0.53

ROE (TTM)

ANIK-270.0%

IPSC-5276.0%

ROA (TTM)

ANIK-204.0%

IPSC-4059.0%

ROIC (TTM)

ANIK-270.0%

IPSC-5276.0%

Cash

ANIK$38M

IPSC$50M

Debt

ANIK$0

IPSC$0

Net Cash/Debt

ANIK$38M

IPSC$50M

Current Ratio (TTM)

ANIK4.48x

IPSC8.28x

Quick Ratio (TTM)

ANIK3.05x

IPSC7.94x

Debt/Equity (TTM)

ANIK0.00x

IPSC0.00x

Debt/Assets (TTM)

ANIK0.0%

IPSC0.0%

Interest Coverage (TTM)

ANIKN/A

IPSCN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

IPSC0.00x

Beta

ANIK0.23

IPSC1.74

52W Performance

ANIK111.9%

IPSC151.9%

YTD Performance

ANIK109.4%

IPSC47.8%

% from 52W High

ANIK-14.4%

IPSC-51.6%

% from 52W Low

ANIK125.8%

IPSC237.9%

Asset Turnover (TTM)

ANIK0.65x

IPSC0.31x

FCF Yield (TTM)

ANIK0.2%

IPSC-33.3%

Earnings Yield (TTM)

ANIK-1.4%

IPSC-41.4%

Dividend Yield (TTM)

ANIKN/A

IPSCN/A

Rule of 40

ANIK-2.0

IPSC-100.0

EV/GP/RG

ANIK0.81

IPSCN/A

Ticker research

View ANIK research View IPSC research

Metric	ANIK Anika Therapeutics Inc	IPSC Century Therapeutics Inc
Market & Valuation
Market Cap	$262M	$265M
Enterprise Value	$224M	$215M
Price	$19.58	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	2.41x
EV/Sales	1.85x	1.98x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	1.19x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-2.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	N/A
Revenue & Growth
Revenue (TTM)	$121M	$0
Revenue Growth (YoY)	-2.5%	-100.0%
Forward Rev Growth	5.2%	385.7%
Profitability
Gross Margin (TTM)	62.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	0.0%
Net Margin (TTM)	-3.1%	0.0%
FCF Margin (TTM)	0.5%	N/A
Net Income (TTM)	$-4M	$-110M
FCF (TTM)	$562K	$-88M
EPS (TTM)	-$0.28	-$0.53
ROE (TTM)	-270.0%	-5276.0%
ROA (TTM)	-204.0%	-4059.0%
ROIC (TTM)	-270.0%	-5276.0%
Financial Health
Cash	$38M	$50M
Debt	$0	$0
Net Cash/Debt	$38M	$50M
Current Ratio (TTM)	4.48x	8.28x
Quick Ratio (TTM)	3.05x	7.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.74
52W Performance	111.9%	151.9%
YTD Performance	109.4%	47.8%
% from 52W High	-14.4%	-51.6%
% from 52W Low	125.8%	237.9%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.31x
FCF Yield (TTM)	0.2%	-33.3%
Earnings Yield (TTM)	-1.4%	-41.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	-100.0
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View IPSC research